Pakistan latest patents query
The latest invention patents collect the data information of Pakistan invention patents from 2000 to 2024, typesetting according to the date of patent publication, including patent number, application date, invention Bibliographic data, abstracts, and specification data of people are convenient for scientific researchers to quickly browse and search for patents.
A pharmaceutical composition comprising n-[2-(2,1,3- benzothiadiazol-5-ylamino)-6 (2,6-dichlorophenyl)pyrido[2,3-d] pyrimidin-7-yl]-n'-(1,1-dimethylethyl-urea
UndeterminedPK140911A
Owner:SANOFI AVENTIS SA
A pharmaceutical composition comprising (2R,cis)-4-amino-1-(2-hydroxymethyl-1,3oxathiolan-5-yl)-[1H]-pyrimidin-2-one (-)2’,3’, dideoxy, 3’-thiacytidine.
UndeterminedPK140896A
Owner:GLAXO GROUP LTD
A noval outer cover of ball stuffed with combination of fibrous, synthetic and rubber meterial
UndeterminedPK201000778A0
Owner:CH BASHIR AHMED BHALLI
MycoHerb and Dairy Booster AQ for Farm Animals
PendingPK202600743A0
Owner:DR MUHAMAMD MOBASHAR ASSOCIATE PROFESSOR +4
Polycyclic compounds as lyosphosphatidic acid receptor antagonists
UndeterminedPK201000829A0
Owner:AMIRA PHARMA INC
Processes and apparatuses for purifying greenhouse gases
UndeterminedPK201000799A0
Owner:HYDROGEN ENERGY INT
Sustainable hydroxypropyl-b-cyclodextrin carbonate nanosponges, process for preparation, drug delivery compositions comprising the same and pharmaceutical applications
PendingPK202600731A0
Owner:PROF DR SADIA JAVED +1
New dihydroindolone compounds, a process for their preparation and pharmaceutical compositions containing them.
UndeterminedPK201000675A0
Owner:LES LAB SERVIER SA
Substituted imidazole compounds for inhibiting aromatase activity.
UndeterminedPK201000892A0
Owner:NOVARTIS AG
Sublingual and buccal film compositions
UndeterminedPK201000688A0
Owner:RECKITT BENCKISER HEALTHCARE (UK) LTD
A therapeutic antibody, method for its preparation and Pharmaceutical composition comprising thereof
UndeterminedPK141030A
Owner:GLAXO GROUP LTD
Oxycodone hydrochloride having less than 25 ppm 14-hydrooxycodeinone
UndeterminedPK140957A
Owner:EURO CELTIQUE SA
Herbicidal composition comprising certain phenylsulfonyl urea
UndeterminedPK140931A
Owner:BAYER CROPSCIENCE AG
Water disposal Perforated floor Tile System
UndeterminedPK201000805A0
Owner:HAMZA AFZAAL S O AFZAAL MUSTAFA +1
Adamantyl iminocarbonylsubstituted pyrimidines as inhibitors of 11betahsd1 826.
UndeterminedPK201000880A0
Owner:ASTRAZENECA AB
Heterocyclyl pyrazolopyrimidine analogues as jak inhibitors.
UndeterminedPK201000886A0
Owner:CELLZOME LTD
Intelligent Tea Brewing and Vending System with User Authentication
PendingPK202600732A0
Owner:BAHRIA UNIV
Device for preventing the explosion of an element of an electrical transformer
UndeterminedPK141015A
Owner:MEGNIER PHILIPPE
Novel modified synthesis insecticidal genes and the development of insectresistant cotton
UndeterminedPK140980A
Owner:BIOCENTURY TRANSGENE CHINA
Disubstituted 9h-pyridino[3,4-b]indole derivatives, preparation thereof and therapeutic use thereof
UndeterminedPK201001015A0
Owner:SANOFI AVENTIS SA
Disperse dye mixtures, their preparation and use
UndeterminedPK201000727A0
Owner:DYSTAR COLOURS DISTRIBUTION GMBH
Radio link control unacknowledged mode header optimization method
UndeterminedPK140978A
Owner:NOKIA CORP
Blended fiber yarns and fabrics including oxidized polymeric fibers.
UndeterminedPK201000893A0
Owner:INVISTA TECHNOLOGIES SARL(CH)
N-(cyanophenyl) pyrazolecarboxamide formulation
UndeterminedPK201000762A0
Owner:EI DU PONT DE NEMOURS & CO
Method and plant for the thermo-chemicla treatment and utilization of carbonaceous materials
UndeterminedPK201000966A0
Owner:RV LIZENZ AG
Emamectin composition comprising a combination of emamectin and lufenuron
UndeterminedPK140930A
Owner:SYNGENTA PARTICIPATIONS AG
N-(5-chloro-2-pyridinyl)[[4-dimethyalamino)iminomethyl]amino]-5-methoxy-benzamide compound
UndeterminedPK201000916A0
Owner:MILLENNIUM PHARMACEUTICALS INC
A sustained release formulation comprising a gelling agent and a pharmaceutically acceptable salt of 11-[4-[2-(2-hydroxyethoxy)ethyl]-1-piperazinyl]dibenzo-[b,f][1,4]thiazepine.
UndeterminedPK140904A
Owner:ASTRAZENECA UK LTD
Use of ferroquine in the treatment or prevention of malaria
UndeterminedPK201000909A0
Owner:SANOFI AVENTIS SA
A sustained release composition comprising a gelling agent and 11-[4-[2-(2-hydroxyethoxy) ethyl]-1-piperazinyl] dibenzo-[b,f][1,4] thiazepine.
UndeterminedPK140895A
Owner:ASTRAZENECA UK LTD
A process and reactor for oxidation of ammonia in the production of nitric acid
PendingPK144879A
Owner:CASALE SA
Process for the reduction of aldehyde concentration in a target stream.
UndeterminedPK140902A
Owner:CELANESE INTERNATIONAL CORP
Treatment of acute ischemic stroke or intracranial bleeding with tPa and carbamylated erythropoietin
UndeterminedPK201000965A0
Owner:H LUNDBECK AS
A pharmaceutically acceptable salt or ester of a substituted 1h-tetrazolyl spiro[chroman-2,4'-piperidine]-1-one compound.
UndeterminedPK140891A
Owner:MERCK & CO INC +1
Pharmaceutically acceptable salt of a substituted n, n', n'trialkylethanediamide compound.
UndeterminedPK201000863A0
Owner:MERCK SHARP & DOHME CORP
5-[4-(2-methylphenyl)-3-hydroxy-4H 1,2,4-triazol-5-yl]-2,4-dihydroxy-N methyl-N-butylbenzamide.
UndeterminedPK140963A
Owner:MERCK PATENT GMBH
Cyclohexylpyrazole-lactam derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1.
UndeterminedPK140885A
Owner:ELI LILLY & CO
A method of treating hepatitis c viral (HCY) infection
UndeterminedPK201000775A0
Owner:BOEHRINGER INGELHEIM INT GMBH
Modular low-voltage LED signage track system with toolless magnetically-retained interchangeable alphanumeric character housings
PendingPK202600739A0
Owner:MUHAMMAD AHSAN ANSARI
Fused pyrazine compounds as their salts, useful for the treatment of degenerative and inflammatory diseases
UndeterminedPK201000918A0
Owner:GALAPAGOS NV
An improved fuel catalyst device, called Economax, for optimizing combustion and improving engine performance.
UndeterminedPK140986A
Owner:ZAHEER ALI MALIK
A method for marking a composition of edible material.
UndeterminedPK140987A
Owner:EISAI R&D MANAGEMENT CO LTD
Solid forms of 4-{(r)-(3 aminophenyl)[4-(4-fluorobenzyl) piperazin-1-yl]methyl}-n, n diethylbenzamide, compositions thereof, and uses therewith
UndeterminedPK201000976A0
Owner:ASTRAZENECA AB
Sheet packaging material for producing sealed packages of pourable food products.
UndeterminedPK201000710A0
Owner:TETRA LAVAL HLDG & FINANCE SA (A CO INC UNDER THE LAWS OF SWITZERLAND)
Pharmaceutical aerosol formulations of formoterol and beclometasone dipropionate
ActivePK201000836A0
Owner:CHIESI FARMACEUTICI SPA
Separation of carbon dioxide from a mixture of gases
UndeterminedPK201000701A0
Owner:BP ALTERNATIVE ENERGY INT
A barrier coated thermo-mechanically stable, heat sealable film, a packaging laminate comprising the film, a packaging container formed from the packaging laminate and a method for the production of the film
UndeterminedPK201000795A0
Owner:TETRA LAVAL HOLDINGS & FINANCE SA
Pharmaceutical Compostion comprising of inclusion complexes of aryl-heterocyclic salt
UndeterminedPK140938A
Owner:PFIZER INC
Compounds and compositions as protein kinase inhibitors
UndeterminedPK201000740A0
Owner:NOVARTIS AG +1
Compositions and methods for treating inflammatory disorders
UndeterminedPK201000908A0
Owner:EISAI R&D MANAGEMENT CO LTD
Method of treating proliferative disorders and other pathological conditions mediated by bcr-abl, c-kit, ddr1, ddr2 or pdgf-r kinase activity
ActivePK201000967A0
Owner:NOVARTIS AG
A method for enhancing asparagine and protein level corn plants and seeds
UndeterminedPK140961A
Owner:MONSANTO TECHNOLOGY LLC
Steroidal compounds as melanogenesis modifiers and uses thereof.
UndeterminedPK201000870A0
Owner:UNILEVER PLC
(2S,4S,5S,7S)-5-amino-N-(2 carbamoyl-2-methylpropyl)-4 hydroxy-2-isopropyl-7-[4-methoxy-3 (3-methoxypropoxy) benzyl]-8 methyl-nonanamide
UndeterminedPK201000769A0
Owner:M S WERRICK PHARMACEUTICALS
Fuded heterocyclic compounds as orexin receptor modulators.
UndeterminedPK201000881A0
Owner:JANSSEN PHARMA NV
Fluoro-substituted 3,5-dicyano-4-(1h indazol-5-yl)-2,6-dimethyl-1,4 dihydropyridine derivatives and mthods of use thereof
UndeterminedPK201000830A0
Owner:BAYER SCHERING PHARMA AG
Pegylated interferon alpha-2A and ribavarin for the treatment of chronic Hepatitis C.
UndeterminedPK140984A
Owner:F HOFFMANN LA ROCHE & CO AG
Mother solutios with a high concentration of polymer based on oils of vegetable and / or animal origin for preparing bitumen / polymer compositions.
UndeterminedPK201000865A0
Owner:TOTAL RAFFINAGE MARKETING
Augmented Reality and Artificial Intelligence Based Smart Circuit Training System with PCB Fault Detection
PendingPK202600733A0
Owner:BAHRIA UNIV
A controlled release pharmaceutical composition comprising a copolymer
UndeterminedPK140921A
Owner:EURO-CEL TIQUE SA
Transdermal dispensing apparatus and methods
UndeterminedPK201000843A0
Owner:ELI LILLY & CO AIRCOM MNUFACTURING INC
Process for the development of buckwheat gluten free biscuits
UndeterminedPK201000798A0
Owner:MRS HAMIDA ABID +3
Process for the preparation of 1,6,2,3-dianhydro-β-D-mannopyranose
UndeterminedPK140894A
Owner:SANOFI AVENTIS SA
Induction of geminiviral resistance in contton plants
UndeterminedPK140944A
Owner:NAT INST FOR BIOTECHNOLOGY & GENETIC ENG (NIBGE)
Compounds as lysophosphatidic acid receptor antagonists
UndeterminedPK201000828A0
Owner:AMIRA PHARMA INC
Compounds and methods for kinase modulation, and indications therefor
UndeterminedPK201000937A0
Owner:JIAZHONG ZHANG +4
Pharmaceutically acceptable salt or solvate of aryl-substituted n-[6-amino-5-aryl-pyridin-2-yl]-carboxamide derivatives
UndeterminedPK141041A
Owner:PFIZER LTD
Derivatives of pyridino-pyridinones, preparation thereof and application thereof in therapeutics
UndeterminedPK201000969A0
Owner:SANOFI AVENTIS SA
New diosmetin compound, a process for its preparation and pharmaceutical composition containing it
UndeterminedPK141038A
Owner:LES LAB SERVIER SA
New compounds of the hexahydrocyclopenta[b]pyrrole type, a process for their preparation and pharmaceutical compositions containing them
UndeterminedPK201001011A0
Owner:LES LAB SERVIER SA
System and Method for Occlusion-Enhanced Photoplethysmoqraphv Non-Invasive Glucose Estimation Using Artificial Intelligence
PendingPK202600742A0
Owner:NED UNIV OF ENG & TECH
Profile system, extrusion die for producing the profile system and method for producing the profile system.
UndeterminedPK201000888A0
Owner:GREINER TOOL TEE GMBH
Use of 4-aminopyridine to improve neuro-cognitive and / or neuropsychiatric impairment in patients with demyelinating and other nervous system conditions.
UndeterminedPK201000700A0
Owner:ACORDA THERAPEUTICS INC
Enantiomer, diastereoisomer or a pharmaceutically acceptable salt of a substituted 2,6-quinolinyl containing compound
UndeterminedPK140835A
Owner:UCB PHARMA SA
A medicament related to mirtazapine for the treatment of hot flush
UndeterminedPK140856A
Owner:AKZO NOBEL NV
Chelating compound, and method of use of, poly(2-octadecyl-butanedioate) and the corresponding acid, poly(2-octadecyl butanedioate
UndeterminedPK201000571A0
Owner:JOSEPH P LAURINO
Solid form of an anti-endothelial growth factor receptor (EGFR) antibodies
UndeterminedPK140831A
Owner:MERCK PATENT GMBH
Novel pyrimidine derivatives and their use in the treatment of disease 757
UndeterminedPK201000432A0
Owner:ASTRAZENECA AB +1
A disinfection composition comprising an oxidising biocide and a delayed release biocide quencher
UndeterminedPK140866A
Owner:UNILEVER PLC
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
UndeterminedPK201000444A0
Owner:ABBOTT LAB INC
Polyester synthetic fiber treatment agent containing (POLY)oxyalkylene derivative and specific inorganic acid and organic phosphoric acid ester compounds, and related compositions and method
ActivePK144759B
Owner:TAKEMOTO OIL & FAT CO LTD
Process for preparing crystalline anhydrous anticholinergic tiotropium bromide
UndeterminedPK140870A
Owner:BOEHRINGER INGELHEIM PHARMA GMBH & CO KG